{"product_id":"cardiovascular-effects-of-inhaled-ultrafine-and-nano-sized-particles-isbn-9780470433539","title":"Cardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles","description":"This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.  FOREWORD.  \u003cp\u003ePREFACE.\u003c\/p\u003e \u003cp\u003eTHE EDITORS.\u003c\/p\u003e \u003cp\u003eCONTRIBUTORS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART I. ISSUE FRAMING.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 1\u003c\/b\u003e OVERVIEW (Flemming R. Cassee and Morton Lippmann).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 2\u003c\/b\u003e ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION (Krishnan Bhaskaran, Shakoor Hajat, and Liam Smeeth).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 3\u003c\/b\u003e CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH (Ranjini M. Krishnan, Joel Kaufman, and Gerard Hoek).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART II. EXPOSURE.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 4\u003c\/b\u003e PARTICLE CHARACTERIZATION (Thomas A.J. Kuhlbusch and Christof Asbach).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 5\u003c\/b\u003e EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES (Timo Lanki, Josef Cyrys, H.-Erich Wichmann, and Jeroen de Hartog).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 6\u003c\/b\u003e FROM EXPOSURE TO DOSE (Werner Hofmann and Bahman Asgharian).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 7\u003c\/b\u003e TRANSLOCATION OF INHALED NANOPARTICLES (Wolfgang G. Kreyling, Winfried Möller, Otmar Schmid, Manuela Semmler-Behnke, and Günter Oberdörster).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 8\u003c\/b\u003e ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLES (Andrew J. Ghio and Yuh-Chin T. Huang).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART III. METHODOLOGY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 9\u003c\/b\u003e IN VITRO STUDIES (Per E. Schwarze and Gerrit M. Alink).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 10\u003c\/b\u003e EXPERIMENTAL STUDIES IN ANIMALS (Urmila P. Kodavanti, Lung-Chi Chen, and Daniel L. Costa).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 11\u003c\/b\u003e HUMAN EXPOSURE STUDIES (Jeremy P. Langrish, Mark W. Frampton, and Anders Blomberg).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 12\u003c\/b\u003e PANEL STUDIES (Joel Schwartz).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eA. ATHEROGENESIS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 13\u003c\/b\u003e PARTICULATES AND OXIDATIVE STRESS (Steffen Loft, Roel P.F. Schins, and Peter Møller).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 14\u003c\/b\u003e ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER (Thomas Sandström and David Newby).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 15\u003c\/b\u003e INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS (Carlijne Hassing, Maarten J.M. Cramer, and Marcel Th.B. Twickler).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 16\u003c\/b\u003e INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANS (Barbara Hoffmann and Nino Künzli).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 17\u003c\/b\u003e EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE (Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl, and Dennis W. Wilson).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 18\u003c\/b\u003e PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME (Robert D. Brook and Sanjay Rajagopalan).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 19\u003c\/b\u003e PARTICLES AND THE VASCULAR ENDOTHELIUM (Nicholas L. Mills and Mark R. Miller).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eB. VASCULAR DYSFUNCTION.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eC. THROMBOSIS.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 20\u003c\/b\u003e PARTICLES, COAGULATION, AND THROMBOSIS (Evren Kilinç, Goran Rudež, Henri M.H. Spronk, Abderrahim Nemmar, Moniek P.M. de Maat, Hugo ten Cate and Marc F. Hoylaerts).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 21\u003c\/b\u003e PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS (Qinghua Sun and Xiaohua Xu).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART IV. PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eD. ARRHYTHMIA.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 22\u003c\/b\u003e PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM (Swapna Upadhyay, Alison Elder, Wayne E. Cascio, and Holger Schulz).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 23\u003c\/b\u003e AIR POLLUTION AND ARRHYTHMIA (Helen C. Routledge and Jonathan N. Townend).\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePART V. ENVIRONMENTAL AND PUBLIC HEALTH POLICY.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 24\u003c\/b\u003e RISK ASSESSMENT (Robert L. Maynard and Jon G. Ayres).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 25\u003c\/b\u003e ENVIRONMENTAL REGULATION OF PARTICULATE MATTER (Richard Damberg, Klaas Krijgsheld, May Ajero, and Sophie Punte).\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCHAPTER 26\u003c\/b\u003e FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY (Ken Donaldson and David B. Warheit).\u003c\/p\u003e \u003cp\u003eINDEX.\u003c\/p\u003e  \"It is timely and detailed in its account of complex issues attending air pollution related to the cardiovascular and cardiopulmonary systems. . . This book could well be the most important occupational and environmental health book I have ever read.\" (Doody's, 16 September 2011)  \u003cp\u003e \u003c\/p\u003e  \u003cp\u003eFlemming R. Cassee is head of the Department of Inhalation Toxicology, deputy head of the Center for Environmental Health, and leader of the program on air pollution and health at the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.\u003c\/p\u003e \u003cp\u003eNicholas L. Mills is a British Heart Foundation Clinical Fellow at the University of Edinburgh and Specialist Registrar in Cardiology at the Royal Infirmary of Edinburgh.\u003c\/p\u003e \u003cp\u003eDavid E. Newby is the British Heart Foundation John Wheatley Chair of Cardiology at the University of Edinburgh. He is a Consultant Interventional Cardiologist at the Royal Infirmary of Edinburgh, Director of the Wellcome Trust Clinical Research Facility, Director of the Clinical Research Imaging Centre, and Director of Research and Development for NHS Lothian.\u003c\/p\u003e  \u003cp\u003eA comprehensive overview of the cardiovascular effects of air pollution\u003c\/p\u003e \u003cp\u003eScientists have known for decades that air pollution causes serious health effects. Only recently has a definitive set of epidemiological and toxicological data become available demonstrating that exposure to particulate air pollution contributes to atherosclerosis and can trigger myocardial ischemia or arrhythmias.\u003c\/p\u003e \u003cp\u003eCardiovascular Effects of Inhaled Ultrafine and Nano-Sized Particles provides a timely and detailed account of the complex issues that determine the impact of air pollution on the cardiovascular system. With contributions from world leaders in the field, it provides an up-to-date review of the key mechanisms involved in the induction and progression of these cardiovascular conditions.\u003c\/p\u003e \u003cp\u003eIntegrating knowledge across such disciplines as epidemiology, toxicology, atmospheric sciences, clinical sciences, and risk assessment, the book:\u003c\/p\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003eIncludes case studies, and both toxicological and epidemiological data\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eReviews the implications for health policy and regulations\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eCovers sources and characterization, methods of exposure, and the impact of particulate matter on cells and systems\u003c\/p\u003e \u003c\/li\u003e \u003cli\u003e \u003cp\u003eDescribes the role of particles in the pathophysiology of cardiovascular disease, and potential environmental and therapeutic interventions\u003c\/p\u003e \u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThis book is a core text for scientists, clinicians, and public health regulators wanting to understand more thoroughly the causality and mechanisms of disease. From procedures to policy, the text is comprehensive and essential for students and professionals alike.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47988887322853,"sku":"NP9780470433539","price":203.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470433539.jpg?v=1761781925","url":"https:\/\/k12savings.com\/es\/products\/cardiovascular-effects-of-inhaled-ultrafine-and-nano-sized-particles-isbn-9780470433539","provider":"K12savings","version":"1.0","type":"link"}